Molecule Details
InChIKeyWDJUZGPOPHTGOT-XUDUSOBPSA-N
Compound NameDigitoxin
Canonical SMILESC[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)11
Pfam Stratification Cross-Family
Avg pChEMBL7.37
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB01396
Drug NameDigitoxin
CAS Number71-63-6
Groups approved withdrawn
ATC Codes C01AA04
DescriptionA cardiac glycoside sometimes used in place of digoxin. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665)

Categories: Antiarrhythmic agents Carbohydrates Cardanolides Cardenolides Cardiac Glycosides Cardiac Therapy Cardiotonic Agents Cardiovascular Agents Compounds used in a research, industrial, or household setting Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index Cytochrome P-450 Substrates Digitalis Glycosides Enzyme Inhibitors Fused-Ring Compounds Glycosides Narrow Therapeutic Index Drugs P-glycoprotein substrates P-glycoprotein substrates with a Narrow Therapeutic Index Potential QTc-Prolonging Agents Protective Agents QTc Prolonging Agents Steroids
Cross-references: BindingDB: 46356 ChEBI: 28544 CHEMBL254219 ChemSpider: 389987 Drugs Product Database (DPD): 10107 C06955 D00297 PDB: F9R PharmGKB: PA449316 PubChem:441207 PubChem:46506035 RxCUI: 3403 Therapeutic Targets Database: DAP000120 Wikipedia: Digitoxin ZINC: ZINC000095862733
Target Activities (11)
Target Gene Organism Category Pfam pChEMBL Type Source
P13637 ATP1A3 Homo sapiens Human PF13246 PF00689 PF00690 PF00122 8.1 IC50 ChEMBL
P54710 FXYD2 Homo sapiens Human PF02038 8.1 IC50 ChEMBL
Q13733 ATP1A4 Homo sapiens Human PF13246 PF00689 PF00690 PF00122 8.1 IC50 ChEMBL
P54709 ATP1B3 Homo sapiens Human PF00287 7.5 Ki ChEMBL;BindingDB
P05026 ATP1B1 Homo sapiens Human PF00287 7.5 Ki ChEMBL
P50993 ATP1A2 Homo sapiens Human PF13246 PF00689 PF00690 PF00122 7.5 Ki ChEMBL;BindingDB
P14415 ATP1B2 Homo sapiens Human PF00287 7.4 Ki ChEMBL;BindingDB
P05023 ATP1A1 Homo sapiens Human PF13246 PF00689 PF00690 PF00122 7.0 Ki ChEMBL;BindingDB
Q6ZQN7 SLCO4C1 Homo sapiens Human PF07648 PF03137 6.9 IC50 ChEMBL;BindingDB
P40763 STAT3 Homo sapiens Human PF00017 PF01017 PF02864 PF02865 PF21354 6.2 IC50 ChEMBL;BindingDB
P0DTD1 rep Severe acute respiratory syndrome coronavirus 2 Pathogen PF13087 PF16251 PF11501 PF12379 PF12124 PF11633 PF06471 PF06460 PF09401 PF20631 PF20633 PF20632 PF19215 PF19216 PF19219 PF19211 PF19218 PF16348 PF19217 PF19213 PF08716 PF08717 PF08710 PF08715 PF06478 PF01661 PF05409 PF00680 6.6 IC50 BindingDB
DrugBank Target Actions (12)
Target Gene Target Name Action Type
P02768 ALB Albumin binder carriers
P05108 P05108 Cholesterol side-chain cleavage enzyme, mitochondrial inhibitor enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P05023 ATP1A1 Sodium/potassium-transporting ATPase subunit alpha-1 inhibitor targets
P05026 ATP1B1 Sodium/potassium-transporting ATPase subunit beta-1 inhibitor targets
P13637 ATP1A3 Sodium/potassium-transporting ATPase subunit alpha-3 inhibitor targets
P14415 ATP1B2 Sodium/potassium-transporting ATPase subunit beta-2 inhibitor targets
P50993 ATP1A2 Sodium/potassium-transporting ATPase subunit alpha-2 inhibitor targets
P54709 ATP1B3 Sodium/potassium-transporting ATPase subunit beta-3 inhibitor targets
P46721 P46721 Solute carrier organic anion transporter family member 1A2 inhibitor transporters
Q6ZQN7 SLCO4C1 Solute carrier organic anion transporter family member 4C1 inhibitor transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 substrate transporters